ATE404545T1 - Acylaminothiazolderivate, verfahren zu deren herstellung und deren verwendung als inhibitoren der produktion von beta-amyloidpeptid - Google Patents
Acylaminothiazolderivate, verfahren zu deren herstellung und deren verwendung als inhibitoren der produktion von beta-amyloidpeptidInfo
- Publication number
- ATE404545T1 ATE404545T1 AT04704255T AT04704255T ATE404545T1 AT E404545 T1 ATE404545 T1 AT E404545T1 AT 04704255 T AT04704255 T AT 04704255T AT 04704255 T AT04704255 T AT 04704255T AT E404545 T1 ATE404545 T1 AT E404545T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- inhibitors
- beta
- amyloid peptide
- acylaminothiazole derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0300703A FR2850380B1 (fr) | 2003-01-23 | 2003-01-23 | Derives d'acylaminothiazole, leur preparation et leur utilisation en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE404545T1 true ATE404545T1 (de) | 2008-08-15 |
Family
ID=32669150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04704255T ATE404545T1 (de) | 2003-01-23 | 2004-01-22 | Acylaminothiazolderivate, verfahren zu deren herstellung und deren verwendung als inhibitoren der produktion von beta-amyloidpeptid |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7563903B2 (de) |
| EP (1) | EP1590337B1 (de) |
| JP (1) | JP2006515888A (de) |
| KR (1) | KR101059669B1 (de) |
| CN (1) | CN100532370C (de) |
| AR (1) | AR042745A1 (de) |
| AT (1) | ATE404545T1 (de) |
| AU (1) | AU2004207658B2 (de) |
| BR (1) | BRPI0406893A (de) |
| CA (1) | CA2511610A1 (de) |
| DE (1) | DE602004015726D1 (de) |
| FR (1) | FR2850380B1 (de) |
| HR (1) | HRP20050637A2 (de) |
| IL (1) | IL169428A (de) |
| MA (1) | MA27610A1 (de) |
| ME (1) | MEP16708A (de) |
| MX (1) | MXPA05007847A (de) |
| NO (1) | NO330415B1 (de) |
| NZ (1) | NZ541147A (de) |
| PL (1) | PL377999A1 (de) |
| RS (1) | RS51168B (de) |
| RU (1) | RU2360907C2 (de) |
| TW (1) | TWI320710B (de) |
| WO (1) | WO2004067520A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1633350B1 (de) * | 2003-06-05 | 2012-10-03 | Elan Pharmaceuticals, Inc. | Acylierte aminosäure-amidyl-pyrazole und verwandte verbindungen |
| ES2389062T3 (es) * | 2006-01-18 | 2012-10-22 | Amgen, Inc | Compuestos de tiazol como inhibidores de proteína cinasa B (PKB) |
| AU2008276521B2 (en) | 2007-07-17 | 2011-11-03 | Amgen Inc. | Heterocyclic modulators of PKB |
| AU2008276512A1 (en) * | 2007-07-17 | 2009-01-22 | Amgen Inc. | Thiadiazole modulators of PKB |
| US8668863B2 (en) | 2008-02-26 | 2014-03-11 | Board Of Regents, The University Of Texas System | Dendritic macroporous hydrogels prepared by crystal templating |
| EP2371421A1 (de) * | 2010-03-04 | 2011-10-05 | Université de Lille 2 Droit et Santé | Liganden von insulinabbauenden Enzymen und ihre Verwendungen |
| EP2508511A1 (de) * | 2011-04-07 | 2012-10-10 | Laboratoire Biodim | Inhibitoren der Virenreplikation, Verfahren zu deren Herstellung und deren therapeutische Verwendung |
| CN103145692B (zh) * | 2013-03-12 | 2014-07-16 | 盐城工学院 | 一种4,5-二氢-6H-环戊烷并[b]噻吩-6-酮的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE296797T1 (de) * | 1996-11-22 | 2005-06-15 | Elan Pharm Inc | N-(aryl/heteroaryl/alkylacetyl) amino saüre amide,pharmazeutische zusammensetzungen damit, und methodenzur inhibierung beta-amyloid peptid freisetzung oder synthese |
| PL196641B1 (pl) * | 1996-12-23 | 2008-01-31 | Elan Pharm Inc | Związki laktamowe i środek farmaceutyczny |
| EP1087951B9 (de) * | 1998-06-18 | 2006-09-13 | Bristol-Myers Squibb Company | Durch kohlenstoff substituierte aminothiazole als inhibitoren von zyclin-abhägigen kinasen |
| AU6229699A (en) * | 1998-10-26 | 2000-05-15 | Sumitomo Pharmaceuticals Company, Limited | Beta-amyloid formation inhibitors |
| GB9823871D0 (en) * | 1998-10-30 | 1998-12-23 | Pharmacia & Upjohn Spa | 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents |
| AR039059A1 (es) * | 2001-08-06 | 2005-02-09 | Sanofi Aventis | Compuesto derivado de acilaminotiazol, su utilizacion, procedimientos para prepararlo, composicion farmaceutica que lo comprende, y compuestos intermediarios |
-
2003
- 2003-01-23 FR FR0300703A patent/FR2850380B1/fr not_active Expired - Fee Related
-
2004
- 2004-01-22 MX MXPA05007847A patent/MXPA05007847A/es active IP Right Grant
- 2004-01-22 BR BR0406893-9A patent/BRPI0406893A/pt not_active IP Right Cessation
- 2004-01-22 JP JP2006502115A patent/JP2006515888A/ja not_active Ceased
- 2004-01-22 EP EP04704255A patent/EP1590337B1/de not_active Expired - Lifetime
- 2004-01-22 CA CA002511610A patent/CA2511610A1/en not_active Abandoned
- 2004-01-22 AR ARP040100169A patent/AR042745A1/es unknown
- 2004-01-22 RS YUP-2005/0563A patent/RS51168B/sr unknown
- 2004-01-22 KR KR1020057013441A patent/KR101059669B1/ko not_active IP Right Cessation
- 2004-01-22 AT AT04704255T patent/ATE404545T1/de not_active IP Right Cessation
- 2004-01-22 NZ NZ541147A patent/NZ541147A/en not_active IP Right Cessation
- 2004-01-22 RU RU2005126608/04A patent/RU2360907C2/ru not_active IP Right Cessation
- 2004-01-22 ME MEP-167/08A patent/MEP16708A/xx unknown
- 2004-01-22 DE DE602004015726T patent/DE602004015726D1/de not_active Expired - Lifetime
- 2004-01-22 CN CNB2004800027812A patent/CN100532370C/zh not_active Expired - Fee Related
- 2004-01-22 AU AU2004207658A patent/AU2004207658B2/en not_active Ceased
- 2004-01-22 PL PL377999A patent/PL377999A1/pl not_active Application Discontinuation
- 2004-01-22 WO PCT/FR2004/000140 patent/WO2004067520A1/fr active IP Right Grant
- 2004-01-27 TW TW093101748A patent/TWI320710B/zh not_active IP Right Cessation
-
2005
- 2005-06-27 IL IL169428A patent/IL169428A/en not_active IP Right Cessation
- 2005-07-12 HR HR20050637A patent/HRP20050637A2/hr not_active Application Discontinuation
- 2005-07-12 MA MA28385A patent/MA27610A1/fr unknown
- 2005-07-21 US US11/186,507 patent/US7563903B2/en not_active Expired - Fee Related
- 2005-07-22 NO NO20053588A patent/NO330415B1/no not_active IP Right Cessation
-
2009
- 2009-06-22 US US12/488,658 patent/US7879889B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE476412T1 (de) | Acyl-4-carboxy-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung | |
| ATE381552T1 (de) | Derivate von 1-piperazin- und 1- homopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms | |
| DE502005010912D1 (de) | Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| DE602004015570D1 (de) | Makromolekulare ketoaldehyden und verfahren zu dessen herstellung | |
| ATE380184T1 (de) | Derivate von alkylpiperazin- und alkylhomopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms | |
| DE60333438D1 (de) | Beschichtete gefässprothesen, verfahren zu deren herstellung und verwendung derselben | |
| DE60324376D1 (de) | Halbleiterbauelement und Verfahren zu dessen Herstellung | |
| ATE452879T1 (de) | Heterozyklisch substituierte benzoylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| ATE331705T1 (de) | Alpha-aminosäure-derivate, verfahren zu deren herstellung sowie deren verwendung als dipeptidylpeptidase-iv inhibitoren (dpp iv) | |
| ATE535518T1 (de) | Derivate von piperidinyl- und piperazinylalkylcarbamaten, verfahren zu deren herstellung und deren verwendung in therapeutika | |
| ATE346065T1 (de) | Substituierte thiazol- benzoisothiazoldioxidderivative, verfahren zu deren herstellung und deren verwendung | |
| DE502004002403D1 (de) | Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer | |
| DE60313818D1 (de) | Dialysator und Verfahren zu dessen Herstellung | |
| ATE327981T1 (de) | Arylisoxazolin-derivative, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel | |
| DE60335812D1 (de) | Biosensor und verfahren zu seiner herstellung | |
| DE60329744D1 (de) | Aminosäurepulver und verfahren zu seiner herstellung | |
| ATE496046T1 (de) | Arylvinylazacycloalkan-verbindungen und verfahren zu deren herstellung und verwendung | |
| ATE384069T1 (de) | Alkyliden-tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer | |
| ATE525382T1 (de) | Azazucker-derivate, heparanase-hemmer, verfahren zu deren herstellung, zusammensetzungen damit und verwendung | |
| DE112004002104A5 (de) | Hochtackige Klebmasse, Verfahren zu deren Herstellung und deren Verwendung | |
| DE60307830D1 (de) | Neue multimerische moleküle, verfahren zu deren herstellung, und deren verwendung zur herstellung von arzneimitteln | |
| ATE478045T1 (de) | Derivate von 4,5-diarylpyrrol, verfahren zu deren herstellung und deren verwendung in therapeutika | |
| ATE404545T1 (de) | Acylaminothiazolderivate, verfahren zu deren herstellung und deren verwendung als inhibitoren der produktion von beta-amyloidpeptid | |
| DE602004031350D1 (de) | Penamkristall und verfahren zu dessen herstellung | |
| ATE404532T1 (de) | Acyl-3-carboxyphenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |